OncoSec Medical Announces $7.2 Million Public Offering

Dec 13, 2012 9:30am EST

OncoSec Medical to Present Data at DNA Vaccines 2012 Conference

Dec 04, 2012 6:08am EST

OncoSec Medical to Present at NYSSA Life Sciences and LD Micro Investor Conferences

Nov 27, 2012 6:08am EST

OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients

Nov 15, 2012 6:02am EST

OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients

Nov 14, 2012 6:06am EST

OncoSec Medical Incorporated Reports Positive Preliminary Efficacy and Safety Results from Phase II Study of ImmunoPulse in Merkel Cell Carcinoma Patients

Oct 23, 2012 6:07am EDT

OncoSec Receives CE Mark for Its Electroporation Device

Oct 17, 2012 6:07am EDT

OncoSec Medical to Present Data at Two Upcoming Conferences

Oct 09, 2012 6:08am EDT

OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference

Oct 02, 2012 6:09am EDT

OncoSec Establishes Clinical Site for Its Phase II Metastatic Melanoma Trial at University of Washington

Sep 25, 2012 6:12am EDT